SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-676766
Filing Date
2016-08-09
Accepted
2016-08-09 16:12:59
Documents
61
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d181205d10q.htm 10-Q 529413
2 EX-10.1 d181205dex101.htm EX-10.1 47593
3 EX-31.1 d181205dex311.htm EX-31.1 6120
4 EX-31.2 d181205dex312.htm EX-31.2 6109
5 EX-32.1 d181205dex321.htm EX-32.1 6371
  Complete submission text file 0001193125-16-676766.txt   3151857

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cfrx-20160630.xml EX-101.INS 468432
7 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20160630.xsd EX-101.SCH 41090
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cfrx-20160630_cal.xml EX-101.CAL 48628
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cfrx-20160630_def.xml EX-101.DEF 134248
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20160630_lab.xml EX-101.LAB 327957
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20160630_pre.xml EX-101.PRE 239214
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 161818048
SIC: 2834 Pharmaceutical Preparations